Advanz Pharma Corporation Ltd. (CXRXF)
Stock Price: $4.60 USD
-0.41 (-8.18%)
Updated Jan 15, 2021 12:54 PM EST - Market closed
| Market Cap | 237.23M |
| Revenue (ttm) | 512.56M |
| Net Income (ttm) | -101.90M |
| Shares Out | 48.91M |
| EPS (ttm) | -2.09 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | January 15 |
| Last Price | $4.60 |
| Previous Close | $5.01 |
| Change ($) | -0.41 |
| Change (%) | -8.18% |
| Day's Open | 4.14 |
| Day's Range | 4.00 - 4.60 |
| Day's Volume | 3,326 |
| 52-Week Range | 2.13 - 14.054 |
News
There are no news available yet.
About CXRXF
ADVANZ PHARMA, a specialty pharmaceutical company, through its subsidiaries, owns or licenses a portfolio of branded and generic prescription products. The company operates in two segments, ADVANZ PHARMA International and ADVANZ PHARMA North America. The ADVANZ PHARMA International segment owns or licenses a portfolio of branded and generic prescription products to wholesalers, hospitals, and pharmacies. This segment's products include Macrobid/Macrodantin to treat bladder infections, such as cystitis and urinary tract infections; Eltroxin, lev... [Read more...]
| Industry Drug Manufacturers-Specialty & Generic | |
| CEO Graeme Neville Duncan | Employees 429 |
| Stock Exchange OTCMKTS | Ticker Symbol CXRXF |